METHODS	A double-blind randomized trial of 300 women with a healthy singleton pregnancy allocated into 4 groups to receive either : 400 microg or 600 microg of sublingual misoprostol , 5 IU of intravenous oxytocin , or 200 microg of intravenous methylergometrine .\